You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

22 December 2020

UNAIDS bids farewell to Fast-Track era with new HIV targets for 2025

New 2025 targets aim to put the world back on track to end AIDS by 2030 following the news that Fast-Track targets were missed.

01 December 2020

3 steps to a happy and healthy sex life – World AIDS Day 2020

Sexual health is about so much more than infection prevention – it’s about being happy with yourself and in your sex life. Help us to spread the word that everyone has a right to pleasurable and safer sex!

10 November 2020

Long-acting PrEP for women – ‘hugely significant’ for the HIV response

News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.

30 October 2020

Strengths and weaknesses of HIV care in Uganda exposed

Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months

29 October 2020

Indonesian HIV care cascade scheme has mixed results

Government initiative increases retention in care by a third but struggles to expand treatment access or reduce deaths among people with HIV.

14 October 2020

66% decline in new HIV patients following introduction of user fees in Nigeria

User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.

07 October 2020

Should men who buy sex be considered a key population?

The first evidence review to focus on men who buy sex – rather than women who sell it – finds a strong association between purchasing sex and HIV.

25 September 2020

Ugandan study finds many are willing to start PrEP but stop it soon after

Study among fisherfolk, sex workers, truck drivers and others at higher risk of HIV finds many are willing to try PrEP – but only for around six weeks.

23 July 2020

Injectable PrEP – an exciting tool, but no silver bullet for adherence

We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.

07 July 2020

Africa hailed for HIV success, but unequal progress means targets will be missed

The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.